Christopher L. Schnieders

Partner

Chris Schnieders devotes his entire practice to civil litigation with an emphasis in the areas of complex pharmaceutical and medical device actions, professional liability actions, and personal injury actions.

Chris has worked extensively in the litigation surrounding Paxil, Prozac, Transvaginal Mesh, Avandia, Yaz, Bextra, Celebrex and Vioxx. Chris’ work in all of these litigations has resulted in hundreds of millions of dollars in recovery to his clients.  Chris has also successfully represented both defendants and plaintiffs in numerous medical malpractice and other professional liability actions. This representation encompassed all facets of litigation, up to, and including, jury verdict.

Chris’ litigation practice has earned him numerous distinctions, including recognition both as a Top 100 Trial Lawyer in the state of Missouri from The National Trial Lawyers and as a Super Lawyer for the state of Missouri starting in 2013.  Chris is also AV rated, the highest rating for legal ability and ethical standards under the peer review system of Martindale-Hubbell, the national legal directory.

Chris is an active member of the American Association for Justice; the Missouri, Illinois, and Kansas Bar Associations; the National Trial Lawyers; and the Kansas City Metropolitan Bar Association. Chris is a graduate of the Kansas City Metropolitan Bar Leadership Academy as well as the Ross T. Roberts Inn of Court Program, and has served as vice chair of the KCMBA Civil Practices Committee. Chris is also a board member of Boys Hope Girls Hope of Kansas City, an organization helping academically capable and motivated boys in need to meet their full potential.  He has also devoted substantial Pro Bono time to indigent persons faced with family court issues.

Currently, Chris is actively involved in representing women injured by their exposure to Essure and individuals injured due to placement of an inferior vena cava (IVC) filter.  Chris is further involved in representing children injured by in utero ingestion of Zofran, a drug prescribed off-label for morning sickness in pregnancy, as well as Clomid/Serophene, a drug used to induce ovulation in women wishing to become pregnant.  In addition to his products liability work, Chris continues to investigate and represent claims involving catastrophic injury and wrongful death.

 

 

 


A press conference was held in St. Louis to outline the action that was filed in federal court to block Bayer-Monsanto from selling its weedkiller product Roundup.

The action details how Black farmers were forced into buying Roundup-resistant seeds and relying on heavier and heavier concentrations of Roundup, which has been the subject of thousands of lawsuits from victims of non-Hodgkins Lymphoma. Since some Black farmers have lower literacy rates and less access to the internet, they were less likely to understand the risks and Bayer-Monsanto made no proactive effort to educate or warn them, the plaintiff attorneys, including Partner and co-counsel in the case Christopher Schnieders, said.

The full press conference can be found here.